bexarotene (Oceanside Pharmaceuticals)


Welcome to the PulseAid listing for the bexarotene drug offered from Oceanside Pharmaceuticals. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Oceanside Pharmaceuticals
NON-PROPRIETARY NAME: bexarotene
SUBSTANCE NAME: BEXAROTENE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, LIQUID FILLED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2015-12-17
END MARKETING DATE: 0000-00-00


bexarotene HUMAN PRESCRIPTION DRUG Details:

Item Descriptionbexarotene from Oceanside Pharmaceuticals
LABELER NAME: Oceanside Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 75(mg/1)
START MARKETING DATE: 2015-12-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68682-003_8f5964b7-0df5-4f2a-b6db-4a055c64d902
PRODUCT NDC: 68682-003
APPLICATION NUMBER: NDA021055

Other BEXAROTENE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional Inc.Bexarotene
Mylan Pharmaceuticals Inc.Bexarotene
Oceanside Pharmaceuticalsbexarotene
Valeant Pharmaceuticals North America LLCTargretin